Editorial comment on: surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
Grabe
Magnus
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001938:Brazil / Q000453:epidemiology; D003556:Cystitis / Q000188:drug therapy / Q000453:epidemiology* / Q000652:urine; D004352:Drug Resistance, Microbial; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D011159:Population Surveillance / Q000379:methods*
D000900:Anti-Bacterial Agents